Download - WHOCC

More documents

Recommendations

Info

Guidelines for ATCvet classification 13th edition WHO Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health P.O.Box 4404 Nydalen N-0403 Oslo Norway Telephone: +47 21078160 Telefax: +47 21078146 E-mail: whocc@fhi.no Website: www.whocc.no
Previous editions: 1992: Guidelines on ATCvet classification, 1st edition 1) 1995: Guidelines on ATCvet classification, 2nd edition 1) 1999: Guidelines on ATCvet classification, 3rd edition 1) 2002: Guidelines for ATCvet classification, 4th edition 2) 2003: Guidelines for ATCvet classification, 5th edition 2) 2004: Guidelines for ATCvet classification, 6th edition 2) 2005: Guidelines for ATCvet classification, 7th edition 2) 2006: Guidelines for ATCvet classification, 8th edition 2) 2007: Guidelines for ATCvet classification, 9th edition 2) 2008: Guidelines for ATCvet classification, 10th edition 2) 2009: Guidelines for ATCvet classification, 10th edition 2) 2010: Guidelines for ATCvet classification, 11th edition 2) 1) Published by the Nordic Council on Medicines 2) Published by the WHO Collaborating Centre for Drug Statistics Methodology
Page 2 and 3: Guidelines for ATCvet classificatio
Page 6 and 7: Preface The Anatomical Therapeutic
Page 8 and 9: Contents 1 Introduction to the ATCv
Page 10: QN - Nervous system................
Page 13 and 14: 1.3 Relationship between the ATCvet
Page 15 and 16: Classification according to the mai
Page 17 and 18: 2.2 Classification of plain prepara
Page 19 and 20: - Proposed ATCvet classification, w
Page 22 and 23: QA ALIMENTARY TRACT AND METABOLISM
Page 24 and 25: QA ALIMENTARY TRACT AND METABOLISM
Page 26 and 27: QA02B DRUGS FOR PEPTIC ULCER AND GA
Page 28 and 29: QA03D QA03DA QA03DB QA03DC ANTISPAS
Page 30 and 31: Combined packages comprising tablet
Page 32 and 33: QA07D QA07DA ANTIPROPULSIVES Antipr
Page 34 and 35: QA10BD QA10BF QA10BG QA10BH QA10BX
Page 36 and 37: QA11GB Ascorbic acid (vitamin C), c
Page 38 and 39: QA12CD QA12CE Fluoride Selenium Sod
Page 40 and 41: QB BLOOD AND BLOOD FORMING ORGANS Q
Page 42 and 43: QB02BC Local hemostatics Gauze, tam
Page 44 and 45: QB05C IRRIGATING SOLUTIONS Preparat
Page 46 and 47: QC CARDIOVASCULAR SYSTEM QC01 QC02
Page 48 and 49: QC CARDIOVASCULAR SYSTEM QC01 QC01A
Page 50 and 51: QC01D VASODILATORS USED IN CARDIAC
Page 52 and 53: QC02DC QC02DD QC02DG QC02K Pyrimidi
Page 54 and 55:
QC03C HIGH-CEILING DIURETICS High-c
Page 56 and 57:
QC05C QC05CA QC05CX CAPILLARY STABI
Page 58 and 59:
QC08D QC08DA QC08DB SELECTIVE CALCI
Page 60 and 61:
QD DERMATOLOGICALS QD01 QD02 QD03 Q
Page 62 and 63:
QD DERMATOLOGICALS This main group
Page 64 and 65:
QD02BB Protectives against UV-radia
Page 66 and 67:
QD05BX Other drugs for keratoseborr
Page 68 and 69:
QD07C CORTICOSTEROIDS, COMBINATIONS
Page 70 and 71:
QD08AH Quinoline derivatives Chloro
Page 72 and 73:
QG GENITO URINARY SYSTEM AND SEX HO
Page 74 and 75:
QG01AA Antibiotics Combinations wit
Page 76 and 77:
QG02CB QG02CC Prolactine inhibitors
Page 78 and 79:
The group is subdivided according t
Page 80 and 81:
QG04B OTHER UROLOGICALS, INCL. ANTI
Page 82:
QG52 PRODUCTS FOR TEATS AND UDDER P
Page 85 and 86:
QH SYSTEMIC HORMONAL PREPARATIONS,
Page 87 and 88:
QH02 CORTICOSTEROIDS FOR SYSTEMIC U
Page 89 and 90:
QH05B QH05BA ANTI-PARATHYROID AGENT
Page 91 and 92:
QI09 QI10 QI11 Q120 IMMUNOLOGICALS
Page 93 and 94:
QI01 QI01A QI01AA QI01AB QI01AC QI0
Page 95 and 96:
QI01C QI01CA QI01CB QI01CC QI01CD Q
Page 97 and 98:
QI01E QI01EA QI01EB QI01EC QI01ED Q
Page 99 and 100:
QI01KV QI01KX Other inactivated vac
Page 101 and 102:
QI03AM QI03AN QI03AO QI03AP QI03AQ
Page 103 and 104:
QI05AH QI05AI QI05AJ Live and inact
Page 105 and 106:
QI07 QI07A QI07AA QI07AB QI07AC QI0
Page 107 and 108:
QI07X QI07XA QI07XB QI07XC QI07XD Q
Page 109 and 110:
QI08B HARE QI08X LEPORIDAE, OTHERS
Page 111 and 112:
QI10AR QI10AS QI10AU QI10AV QI10AX
Page 113 and 114:
QI20AD QI20AE QI20AF QI20AG QI20AH
Page 115 and 116:
QI20DD QI20DE QI20DF QI20DG QI20DH
Page 117 and 118:
QJ ANTIINFECTIVES FOR SYSTEMIC USE
Page 119 and 120:
QJ01D OTHER BETA-LACTAM ANTIBACTERI
Page 121 and 122:
QJ01FG Streptogramins The streptogr
Page 123 and 124:
QJ01XX Other antibacterials Fumagil
Page 125 and 126:
QJ05AH Neuraminidase inhibitors All
Page 127 and 128:
QJ51RB QJ51RC QJ51RD Amphenicols, c
Page 129 and 130:
QL ANTINEOPLASTIC AND IMMUNOMODULAT
Page 131 and 132:
QL02 ENDOCRINE THERAPY Only prepara
Page 134 and 135:
QM MUSCULO-SKELETAL SYSTEM QM01 QM0
Page 136 and 137:
QM01B QM01BA ANTIINFLAMMATORY/ANTIR
Page 138 and 139:
QM03BC Ethers, chemically close to
Page 140 and 141:
QN NERVOUS SYSTEM QN01 QN02 QN03 QN
Page 142 and 143:
QN01B ANESTHETICS, LOCAL Local anes
Page 144 and 145:
QN02AG Opioids in combination with
Page 146 and 147:
QN03AF QN03AG QN03AX Carboxamide de
Page 148 and 149:
QN05B ANXIOLYTICS Preparations used
Page 150 and 151:
Lithium, see QN05AN - Lithium. Comb
Page 152:
QN07C QN07CA ANTIVERTIGO PREPARATIO
Page 155 and 156:
QP ANTIPARASITIC PRODUCTS, INSECTIC
Page 157 and 158:
Optional subgroups should be used o
Page 159 and 160:
QP53BB Organophosphorous compounds
Page 161 and 162:
QR RESPIRATORY SYSTEM Preparations
Page 163 and 164:
QR03 QR03A DRUGS FOR OBSTRUCTIVE AI
Page 165 and 166:
Preparations which contain small am
Page 167 and 168:
QR06AE Piperazine derivatives Cinna
Page 169 and 170:
QS SENSORY ORGANS Preparations for
Page 171 and 172:
QS01E ANTIGLAUCOMA PREPARATIONS AND
Page 173 and 174:
QS01KA Viscoelastic substances Hyal
Page 175 and 176:
QS03 OPHTHALMOLOGICAL AND OTOLOGICA
Page 177 and 178:
QV VARIOUS This group is the most h
Page 179 and 180:
QV04CC Tests for bile duct patency
Page 181 and 182:
QV07AC Blood transfusion, auxiliary
Page 183 and 184:
QV09A CENTRAL NERVOUS SYSTEM This g
Page 185 and 186:
QV09G CARDIOVASCULAR SYSTEM This gr
Page 187 and 188:
QV10X OTHER THERAPEUTIC RADIOPHARMA
Page 190 and 191:
WHO COLLABORATING CENTRE FOR DRUG S
Page 192:
ANNEX II
Page 195:
ORDER FORM - ATCvet PUBLICATIONS Pa
show all

Download - WHOCC

Create successful ePaper yourself

Delete template?

Save as template?